SMTL ID : 4ejn.1

Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.19 Å

Oligo State

monomer

Ligands

1 x 0R4: N-(4-{5-[3-(ACETYLAMINO)PHENYL]-2-(2-AMINOPYRIDIN-3-YL)-3H-IMIDAZO[4,5-B]PYRIDIN-3-YL}BENZYL)-3-FLUOROBENZAMIDE(Non-covalent)

0R4.1: 19 residues within 4Å: Chain A: N.53, N.54, Q.59, L.78, Q.79, W.80, I.84, L.210, T.211, L.264, V.270, V.271, Y.272, R.273, D.274, I.290, T.291, D.292, Y.326 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:N.53, A:Q.79, A:Q.79, A:W.80, A:W.80, A:I.84, A:L.210, A:L.264, A:V.270, A:V.270, A:Y.272, A:Y.272, A:R.273, A:I.290 Hydrogen bonds: A:W.80, A:T.211, A:T.211 Water bridges: A:N.53, A:N.54, A:D.292 pi-Stacking: A:W.80, A:Y.272 pi-Cation interactions: A:R.273

1 x SBT: 2-BUTANOL(Non-covalent)

SBT.2: 3 residues within 4Å: Chain A: M.147, K.163 Ligands: EDO.3 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.163, A:K.163

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 4 residues within 4Å: Chain A: M.147, K.163, R.222 Ligands: SBT.2 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.163, A:K.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ashwell, M.A. et al., Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors. J.Med.Chem. (2012)

Release Date

2012-05-23

Peptides

RAC-alpha serine/threonine-protein kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RAC-alpha serine/threonine-protein kinase

Related Entries With Identical Sequence